Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("REITER MJ")

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 11 of 11

  • Page / 1
Export

Selection :

  • and

HEMODYNAMIC EFFECTS OF ACUTE ATRIOVENTRICULAR SEQUENTIAL PACING IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTIONREITER MJ; HINDMAN MC.1982; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1982; VOL. 49; NO 4; PP. 687-692; BIBL. 32 REF.Article

COMPARISON OF INTRAVENOUS AND ORAL VERAPAMIL DOSINGREITER MJ; SHAND DG; PRITCHETT ELC et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 6; PP. 711-720; BIBL. 22 REF.Article

CLINICAL SPECTRUM OF VENTRICULAR TACHYCARDIA WITH LEFT BUNDLE BRANCH MORPHOLOGYREITER MJ; SMITH WM; GALLAGHER JJ et al.1983; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1983; VOL. 51; NO 1; PP. 113-121; BIBL. 26 REF.Article

COMPARISON OF CROTON OIL AND CANTHARIDIN INDUCED INFLAMMATIONS OF THE MOUSE EAR AND THEIR MODIFICATION BY TOPICALLY APPLIED DRUGSSWINGLE KF; REITER MJ; SCHWARTZMILLER DH et al.1981; ARCH. INT. PHARMACODYN. THER.; ISSN 0003-9780; BEL; DA. 1981; VOL. 254; NO 1; PP. 168-176; BIBL. 12 REF.Article

INTERACTIONS OF A COBRA NEUROTOXIN AND AFFINITY LABELS OF THE ACETYLCHOLINE RECEPTOR IN THE ELECTROPLAX = INTERACTIONS D'UNE NEUROTOXINE DU COBRA ET DES MARQUES D'AFFINITE DU RECEPTEUR DE L'ACETYLCHOLINE DANS LA PLAQUE ELECTRIQUEPRIVES JM; REITER MJ; COWBURN DA et al.1972; MOLEC. PHARMACOL.; U.S.A.; DA. 1972; VOL. 8; NO 6; PP. 786-789; BIBL. 17 REF.Serial Issue

A SYSTEM FOR THE ANALYSIS OF LONG-TERM ELECTROCARDIOGRAPHIC STUDIES IN CLINICAL RESEARCH AND TRAININGLASTRA AA; PRITCHETT ELC; REITER MJ et al.1983; COMPUTERS AND BIOMEDICAL RESEARCH; ISSN 0010-4809; USA; DA. 1983; VOL. 16; NO 4; PP. 340-346; BIBL. 8 REF.Article

ELECTROCARDIOGRAM RECORDING BY TELEPHONE IN ANTIARRHYTHMIC DRUG TRIALSPRITCHETT ELC; ZIMMERMAN JM; HAMMILL KF et al.1982; CHEST; ISSN 0012-3692; USA; DA. 1982; VOL. 81; NO 4; PP. 473-476; BIBL. 12 REF.Article

IS IT SAFE TO USE INTRAVENOUS VERAPAMIL TO TREAT A PATIENT WHO IS TAKING ORAL VERAPAMIL.PRITCHETT ELC; REITER MJ; HAMMILL SC et al.1983; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1983; VOL. 105; NO 2; PP. 329-331; BIBL. 5 REF.Article

PHARMACOKINETICS OF VERAPAMIL: EXPERIENCE WITH A SUSTAINED INTRAVENOUS INFUSION REGIMENREITER MJ; SHAND DG; AANONSEN LM et al.1982; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1982; VOL. 50; NO 4; PP. 716-721; BIBL. 25 REF.Article

PIRMENOL KINETICS AND EFFECTIVE ORAL DOSEHAMMILL SC; SHAND DG; HARRELL FE JR et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 6; PP. 686-691; BIBL. 9 REF.Article

THE ELECTROPHYSIOLOGIC BASIS AND MANAGEMENT OF SYMPTOMATIC RECURRENT TACHYCARDIA IN PATIENTS WITH EBSTEIN'S ANOMALY OF THE TRICUSPID VALVESMITH WM; GALLAGHER JJ; KERR CR et al.1982; AM. J. CARDIOL.; ISSN 0002-9149; USA; DA. 1982; VOL. 49; NO 5; PP. 1223-1234; BIBL. 2 P.Article

  • Page / 1